On March 19, 2021 Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, reported that it will present two posters at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2021, which will take place virtually from April 10-15 and May 17-21, 2021. The posters will describe insights into exoneural biology discovered via Cygnal’s Exoneural Medicine Platform (EMP).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Poster Title: Neural communication to peripheral tumors regulates cancer cell activity
Number: 1450
Presenter: Monica Thanawala, Ph.D.
Poster Title: Novel mechanisms of Neuropilin-1 inhibition result in improved tumor growth inhibition in vivo
Number: 526
Presenters: Shalini Sethumadhavan, Ph.D., and Eric Zhu, Ph.D.
Both posters will be offered virtually, and Cygnal’s presenters will be available to answer questions via the AACR (Free AACR Whitepaper)’s online system during and after the event. The posters will be available for viewing by registered attendees from April 10 until June 21, 2021.